Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone
Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Μαρία Ρούσσου, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis‐Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Κimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis‐Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Αριστέα-Μαρία Παπανώτα, Harikleia Gakiopoulou, Erasmia Psimenou, Maria Irini Tselegkidi, Ourania Tsitsilonis, Ioannis V. Kostopoulos, Evangelos Terpos, Meletios A Dimopoulos (2019). Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone. , 3(20), DOI: https://doi.org/10.1182/bloodadvances.2019000147.
